The immediate-early 1 (IE1) and IE2 proteins encoded by the major immediate-early (MIE) transcription unit of cytomegaloviruses are thought to play key roles in the switch between latentand lytic-cycle infection. Whilst IE2 is essential for triggering the lytic cycle, the exact roles of IE1 have not been resolved. An MIE-exon 4-deleted rat cytomegalovirus (DIE1) failed to synthesize the IE1 protein and did not disperse promyelocytic leukaemia bodies early post-infection, but was still capable of normal replication in fibroblast cell culture. However, DIE1 had a diminished ability to infect salivary glands persistently in vivo and to reactivate from spleen explant cultures ex vivo. Quantification of viral genomes in spleens of infected animals revealed a reduced amount of DIE1 virus produced during acute infection, suggesting a role for IE1 as a regulator in establishing a chronic or persistent infection, rather than in influencing the latency or reactivation processes more directly.
The cytomegaloviruses (CMVs) are a large family of bherpesviruses that are extremely species-specific. Whilst the initial infection is usually asymptomatic, the virus can become latent in multiple organs and reactivate during periods of immunosuppression. Like other herpesviruses, the CMVs display an ordered cascade of gene expression during productive infection (Mocarski et al., 2007) . The immediate-early (IE) genes are expressed shortly after virus entry into the cell, and the major immediate-early (MIE) mRNA is expressed in the presence of cycloheximide in vitro. The IE proteins appear to regulate the expression of many downstream viral genes and are believed to be critical for reactivation processes following the transcriptional activation of the CMV MIE region (Stinski & Isomura, 2008) .
The structural organization of the MIE regions of human CMV (HCMV), African green monkey CMV, murine CMV (MCMV) and rat CMV (RCMV) are very similar to each other (Meier & Stinski, 2006; Sandford et al., 1993) . An enhancer region lies upstream of two spliced genes that share an untranslated leader sequence (exon 1), exon 2, which contains the first ATG, and exon 3. Two proteins are expressed from the MIE locus. In HCMV and RCMV, these are IE1 and IE2, and in MCMV they are IE1 and IE3. Thus, exon 4 is spliced to exon 2/3 to form IE1, whilst alternate splicing of exon 5 to exon 2/3 forms IE2 (IE3 in MCMV; see Fig. 1a ) (Keil et al., 1987; Messerle et al., 1992; Sandford et al., 1993; Stinski et al., 1983) . No viable IE2/IE3 deletion mutants of any CMV have been isolated, suggesting that IE2/IE3 is absolutely essential for virus replication even in cell culture (Angulo et al., 2000; Marchini et al., 2001; White et al., 2004) , but IE1 is generally considered nonessential in cell culture, especially at high m.o.i. Prevention of virus latency or reactivation could provide potential attractive targets for therapeutic intervention, but at present very little is known about these processes in CMV. Partly because of the high levels of CpG suppression of IE1 exon 4, but not of the IE2 exon 5, coding regions compared with the rest of the viral genome (Honess et al., 1989) , and because of its association with metaphase chromosomes, which resembles a feature of Epstein-Barr virus EBNA1 (Lafemina et al., 1989) , the HCMV IE1 protein has at various times been proposed to be involved in the establishment of or reactivation from latency. To study the influence of IE1 in this context, several deletion mutants have been constructed and analysed. Both partial and complete IE1 exon 4 deletion mutants of HCMV have been described (Ahn et al., 1998; Greaves & Mocarski, 1998; Huh et al., 2008; Lee et al., 2004; Mocarski et al., 1996) . They are characterized by defective replication at a low m.o.i. in primary human fibroblasts, a slower lytic replication cycle especially in promyelocytic leukaemia body (PML)-overexpressing cells, greatly reduced ability to form or spread as plaques after DNA transfection, increased apoptosis and a greater susceptibility to inhibi-tion by beta interferon, but none of these have or could be assessed in vivo in human hosts or animal models.
Rodent CMVs have long provided well-established animal models to study latency and reactivation in vivo (Reddehase et al., 2002 (Reddehase et al., , 2008 . By analogy to HCMV, an MCMV IE1 deletion mutant has been constructed that replicates similarly to wild-type (WT) virus at both high and low m.o.i. in vitro, but is attenuated in vivo (Ghazal et al., 2005) . Here, we investigated the influence of IE1 on RCMV (English isolate) replication in vitro and in vivo, as well as its ability to reactivate ex vivo. Despite the similarity in overall MIE region structural organization, there is little similarity (just 15 % identity) at the predicted amino acid level between human, Old World primate and rodent CMV IE1 proteins. The major conserved feature in exon 4 is a glutamate-rich domain found toward the C terminus in all versions. Therefore, they could play very different roles or act through very different mechanisms. To examine the role of IE1 during RCMV replication, we constructed an IE1 mutant virus with a completely deleted exon 4 (DIE1ex4). Virion DNA of a previously described recombinant RCMV with the endogenous RCMV enhancer replaced by the MCMV enhancer preceded by a lox-lacZ-lox cassette (Sandford et al., 2001) was co-transfected with a transfer vector lacking exon 4 ( Fig. 1b ) into rat embryo fibroblast (REF) cells, providing IE1 complementation in trans. Homologous recombination in REF cells resulted in the loss of the lacZ expression cassette and thus in white plaques, and also in reconstitution of the endogenous RCMV enhancer (Fig. 1b) . A revertant virus (RevIE1ex4) was also constructed as a control for the absence of other inadvertent genetic defects by co-transfection of virion DNA with the revertant transfer vector as above, except that screening was for b-galactosidase-positive virus. RevIE1ex4 was passaged through a REF cell line expressing the Cre protein, which resulted in the loss of the lacZ cassette, with one loxP site remaining in the virus. Both recombinant viruses were purified by limiting dilution and analysed by Southern blotting (Fig. 1c ) and DNA sequencing of the MIE region. Relative total virion DNA : p.f.u. ratios were measured to show that DIE1ex4 does not have many more non-infectious particles than WT and that adjacent exons are unaffected (see Supplementary Figs S1 and S2, available in JGV Online).
To verify that the lack of exon 4 resulted in the lack of IE1 protein expression in infected cells at low m.o.i., we performed Western blot analysis using a polyclonal rabbit antiserum that recognizes a domain within exon 3 of both IE1 and IE2. Thus, the 68 kDa IE2 protein could be detected at normal levels but, as expected, DIE1ex4 failed to express any of the 92 kDa IE1 protein (Fig. 1d ). Next, we compared growth characteristics of DIE1ex4 with those of WT RCMV and RevIE1ex4 in fibroblast tissue culture. As has been shown for MCMV (Ghazal et al., 2005) , DIE1ex4 replicated with almost-identical efficiency to WT and RevIE1ex4 viruses at both low and high m.o.i. in this highly permissive cell type (Fig. 1e, f) .
The dispersion of PML nuclear bodies is thought to increase viral transcription efficiency. Both the HCMV and MCMV IE1 proteins are responsible for the disruption of PML-associated nuclear bodies very early after infection (Ahn & Hayward, 1997 Ahn et al., 1998; Ghazal et al., 2005; Nevels et al., 2004; Tang & Maul, 2003; Tavalai et al., 2006; Wilhelmi et al., 2008; Wilkinson et al., 1998; Xu et al., 2001) . To reveal a possible role for RCMV IE1 in PML disruption, REF cells were either mock-infected or infected with WT RCMV, DIE1ex4 or RevIE1ex4. PML bodies were detected by a polyclonal antiserum (Ahn et al., 1998) 8 h post-infection and visualized by fluorescence microscopy (Fig. 2a ). Whereas both WT and RevIE1ex4 dispersed PML bodies normally, DIE1ex4 did not. Both immunofluorescence analysis (IFA) and Western blotting confirmed that there was no change in the pattern or levels of expression of the IE2 protein in typical punctate pre-replication compartment (pre-RC) structures from the mutant virus. Therefore, as DIE1ex4 replicated efficiently in fibroblast cell culture, it seems that the dispersion of PML is not a prerequisite for RCMV to replicate in vitro.
In the rat animal model, WT virus becomes detectable in the salivary gland (by direct virus culture) by 2 weeks postinfection, where it persists for at least 12 weeks thereafter, but is cleared from the spleen by 1 week post-infection before latency is established (not directly culturable). To investigate IE1 biological function in vivo, we compared infections of rats with WT, DIE1ex4 and RevIE1ex4, using 1610 7 p.f.u. administered intraperitoneally. We monitored acute infection by harvesting spleens at 3 days and salivary glands at 16 days post-infection. In spleens, all viruses could be detected in the infected animals by a direct plaque assay (Table 1) . However, virus could be detected in all salivary glands of animals infected with either WT or RevIE1ex4, whereas only five of eight animals infected with DIE1ex4 were positive, with a 10-fold reduction in the number of viral plaques. Thus, DIE1ex4 can replicate normally in the spleen during acute infection and can spread to the salivary gland, but appears to have reduced replication efficiency. Next, we investigated virus persistence in spleen and salivary gland explants. As expected, neither virus could be detected by direct plaque assay at 120 days post-infection in the spleen. In salivary glands, both infectious WT and RevIE1ex4 virus were detectable in all 12 animals, but directly infectious DIE1ex4 virus was only detected in four of 12 animals.
In our infected adult rat model, we define latency as resolution of productive infection at the organismal level, such that virus cannot be detected by direct plaque-assay culture, but can still be detected as stable low levels of DNA and by explant co-cultivation; however, latency in any organ can coexist with productive infection in the salivary glands, as shown in the mouse model (Simon et al., 2006) . To examine whether IE1 plays a role in reactivation from latency in explants at 120 days post-infection, spleens were excised and small pieces were co-cultured on REF cells. Whereas spleens from all 12 WT and RevIE1ex4 virusinfected animals consistently reactivated after 2 weeks culture, only one of 12 spleens from DIE1ex4-infected animals reactivated 3 weeks after explant. Nevertheless, six of the six spleens tested contained mutant viral DNA, as detected by PCR (see Supplementary Fig. S3 , available in JGV Online). Therefore, DIE1ex4 can become latent in the spleen, but demonstrates a reduced ability to reactivate. This points to a substantial, but nevertheless non-essential role for IE1 in reactivation (as virus could be recovered from one spleen) from latency ex vivo, as has recently been reported for an MCMV IE1 deletion mutant (Busche et al., 2009 ).
Mock-infected animals were negative for infectious virus at all time points. In addition, DNA was isolated from infected spleens harvested 120 days post-infection and measured for latent DNA levels with an RCMV IE1-specific probe by quantitative PCR methods described previously (Voigt et al., 2007) . Each sample was measured in duplicate and absolute quantities were calculated by using a calibration curve of serial dilutions of subcloned plasmids containing IE1 or c-myc DNA fragments. Total viral DNA levels were normalized by calculating the IE1 : 100 copies c-myc ratio. For both the WT and RevIE1ex4 viruses, ratios ranged between 0.03 and 6.20 for WT-infected and between 0.08 and 6.70 for RevIE1ex4-infected animals. In contrast, ratios for animals infected with DIE1ex4 ranged from 0.005 to 0.040 (Fig. 2b) . Therefore, DIE1ex4 can evidently become latent in the spleen, but its ability to reactivate is severely compromised. Whereas the overall effect of restricted reactivation must be caused by the deletion in IE1, it is not necessarily related to any direct qualitative deficiency of the mutant viral genomes present to become latent or to reactivate, but may rather simply reflect the lower quantity of mutant virus present. Less mutant virus was detectable in the spleen, and therefore the Acute infection was monitored in spleens 3 days post-infection (six animals each) and in salivary glands 16 days post-infection (eight animals each). WT virus and RevIE1ex4 could be detected in all spleens and salivary glands, whereas DIE1ex4 was only detectable in five of eight salivary glands with an approx. 10-fold lower amount of virus present. DIE1ex4 was also found in only four of 12 animals in salivary glands 120 days post-infection. In contrast to WT virus and RevIE1ex4, DIE1ex4 could only be reactivated from one of 12 spleens ex vivo.
Virus detected in:
WT RevIE1ex4 chance of it being reactivated is likely to be small (Reddehase et al., 1994) . The IE1 deletion also results in an acute replication deficit, which is in accordance with a lower titre in the salivary gland at day 16 post-infection. However, because DIE1ex4 is attenuated in vivo, the infection conditions probably did not provide equal levels of multiplication of the viruses, and thus did not produce an equivalent viral genome load during latency.
To exclude contamination with WT or RevIE1ex4 virus in this one reactivated animal and to see whether the reduced acute replication in vivo plus reduced reactivation of ex vivo DIE1ex4 was related to the lack of IE1 protein expression, viruses were isolated from salivary glands that had been persistently infected, as well as from spleens from which virus had been reactivated ex vivo. Recovered viruses were grown on REF cells and lysates were analysed by Western blot assays. Again, only 68 kDa IE2 but not 92 kDa IE1 protein was detected (see Supplementary Fig. S4 , available in JGV Online).
Overall, our results indicate greatly reduced levels of acute replication by RCMV lacking the IE1 gene in the in vivo model in the salivary gland, which evidently lead to much lower levels of stably maintained latency and of reactivation in the spleen. The results are consistent with the findings of reduced virulence and lower virus titres for MCMV lacking IE1 in adult BALB/c and SCID mice (Ghazal et al., 2005) , although these authors did not address latency or reactivation. Similar findings were also recently described in a newborn mouse model (Busche et al., 2009 ). However, by using 10-to 100-fold higher compensatory levels of MCMV lacking IE1 than of WT controls to generate equal levels of established latency, the latter authors measured stable latency and used three distinct criteria for reactivation (including lung explants), but found no evidence for a role of IE1 in these two latter aspects of MCMV biology. Therefore, we can only conclude that there is a strong positive effect of IE1 on acute infection levels in vivo, whereas it is quite plausible that RCMV DIE1ex4 (like MCMV) has no defect in the ability to maintain or reactivate from latency.
